Development and validation of hierarchical signature for precision individualized therapy based on the landscape associated with necroptosis in clear cell renal cell carcinoma. - Yao GS; Dai JS; Fu LM; Lin J; Tan ZP; Dai L; Chen W; Luo JH; Wei JH (Frontiers in pharmacology, 2025)